Palmitate activates the NF-kappaB transcription factor and induces IL-6 and TNFalpha expression in 3T3-L1 adipocytes.

Department of Animal Sciences, Center for Comparative Medicine, Purdue University, West Lafayette, IN 47907-2054, USA.
Journal of Nutrition (Impact Factor: 4.23). 08/2005; 135(8):1841-6.
Source: PubMed

ABSTRACT Fatty acids and their metabolites regulate gene expression and immunological pathways. Furthermore, obese individuals frequently have increased circulating fatty acid concentrations, and localized inflammation in adipose tissue may facilitate the systemic inflammation associated with the insulin resistance of obesity. Although palmitate induces inflammation (i.e., activates proinflammatory pathways) in myotubes, the effects of fatty acids on inflammatory processes in adipocytes have not been established. Therefore, we examined the potential for palmitate, laurate, and docosahexaenoic acid (DHA) to modulate inflammation in 3T3-L1 adipocytes. Palmitate, but not DHA or laurate, induced nuclear factor kappaB (NF-kappaB)-driven luciferase activity and interleukin-6 (IL-6) expression (P < 0.05). Inhibition of fatty acyl Co-A synthase (FACS) with triacsin C suppressed palmitate-induced NF-kappaB activation (P < 0.05), but caused an additive increase in palmitate-induced IL-6 expression (P < 0.05). Disrupting mitogen-activated protein kinase/Erk kinase (MEK) and protein kinase C (PKC) activity with U0126 and Bisindolylmaleimide (Bis), respectively, suppressed palmitate-induced IL-6 expression (P < 0.05), but had no effect on NF-kappaB reporter gene activity (P > 0.05). However, the phosphoinositide-3 kinase (PI3K) inhibitor, wortmannin, alone and additively with palmitate, activated the NF-kappaB reporter gene and induced IL-6 expression (P < 0.05). Palmitate also induced the mRNA expression of tumor necrosis factor alpha (TNFalpha) (P < 0.05), but the increase in mRNA abundance was not reflected in a greater protein concentration in the media (P > 0.05). These data indicate that palmitate induces inflammation in adipocytes, and that this is not a generalized effect of all SFA. Furthermore, PI3K may act constitutively to suppress inflammation. Consequently, inhibition of this enzyme may promote and exacerbate the inflammation in adipose tissue that is associated with obesity and insulin resistance.

  • Cahiers de Nutrition et de Diététique 01/2015; DOI:10.1016/j.cnd.2014.12.001
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The approaches to alleviate low-grade systemic inflammation during postprandial period are still controversial at present. The aims of this article were to review the possible negative effects of postprandial inflammation and to provide potential way to prevent the risks to health during postprandial period through understanding the possible mechanism. Postprandial inflammation may lead to chronic low-grade systemic inflammation. Previous evidence showed that consumption of saturated fats, the elevation of circulating free fatty acids and high levels of blood glucose may lead to increased postprandial inflammation via activated NF-κB pathway, whereas, dietary with low GI, low saturated fats, and fiber-rich appeared to attenuate the postprandial inflammatory responses via down-regulating the NF-κB pathway. Furthermore, it has been suggested that weight loss may successfully lead to a significant reduction in postprandial inflammatory responses. Many studies indicated that exercise served as anti-inflammatory, however no sufficient and convincing evidence proves that exercise alleviated the subsequent postprandial inflammatory responses to date. Therefore, more studies are warranted to investigate the possible mechanisms of how different exercises and diet/meal/nutrients affect low-grade systemic inflammation.
    Current Topics in Nutraceutical Research 09/2013; 11(4):129-136. · 0.19 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Here we sought to evaluate the effect of palmitate on cytokine and PPAR activity/expression. We investigated the effect of BSA conjugated palmitate and oleate on PPAR activity, PPAR-α and δ expression, as well as the expression of cytokines and key factors responsible forβ-oxidation by qRT-PCR and western blotting in primary rat neonatal cardiomyocytes (NCMs). Furthermore we evaluated the effect of anti-inflammatory actions of AICAR and PPAR agonists on cytokine expression and cell death in palmitate treated NCMs. We found that palmitate caused down regulation of PPARs and increased cytokine expression and cell death, all of which was significantly attenuated by the co-administration of either AICAR or PPAR agonists. This work supports the pro-inflammatory actions of intracellular lipid and provides further insight into the pathological mechanism of cardiac lipotoxicity as occurs in diabetic hearts.
    Biochemical and Biophysical Research Communications 02/2015; 459(1). DOI:10.1016/j.bbrc.2015.02.062 · 2.28 Impact Factor

Full-text (2 Sources)

Available from
May 23, 2014